Home > Symposium 2009 Videos
Symposium 2009 Videos
PERSONALIZED MEDICINE THE CONSUMER PERSPECTIVE
- What does the public know and think about personalized medicine?
- Who seeks genomic risk assessments and why?
- How does the Navigenics genomic risk assessment work?
Dr. Joseph Cappella talks about public attitudes of personalized medicine based on online deliberations with a national sample.
Dr. Sarah Gollust outlines the demographics and motivations of a sample of early adopters of personalized medicine.
Elissa Levin describes the process used by Navigenics to collect and analyze samples.
Panel 1 Audience Questions
Why are early adopters in genomic risk assessment studies so confident about their genetic knowledge?
How does Navigenics testing work for patients who are getting a cancer risk assessment but who may have an underlying mutation (eg. BRCA1/2) which is not on the Navigenics panel?
Is "personalized medicine" the correct label?
EXAMPLES OF PERSONALIZED MEDICINE IN ACTION
- A personalized smoking cessation program
- Targeting cancer therapy based on tumor genetics
- A culturally-tailored genetic counseling approach
Dr. Caryn Lerman outlines evidence that would support a genetically tailored smoking cessation therapy.
Dr. Kate Nathanson talks about how advances in somatic genetics are used to target cancer therapies in melanoma.
Dr. Chanita Hughes Halbert describes the development of a genetic counseling program tailored for the African American community.
Panel 2 Audience Questions
Is the culturally tailored genetic counseling used by Dr. Hughes-Halbert as effective as standard genetic counseling?
What types of barriers would we encounter with a program for smoking cessation using personalized therapies such as those described by Dr. Lerman?
Would the type of personalized therapy Dr. Lerman described for smoking cessation be applicable as a preventative treatment?
THE FUTURE OF PERSONALIZED MEDICINE
- How will the use of personalized medicine help improve healthcare?
- Are medical professionals prepared to deliver genomic medicine for common diseases?
- How can genomic medicine be used to reduce disparities and increase certainty in the clinic?
Dr. Steven Udvarhelyi discusses the financial and medical benefits of using personalized medicine to advance healthcare.
Can insurance companies reassure patients that their personal genetic information will not be misused?
Once genetic information is shared with the primary care physician is it no longer protected under GINA?
Joseph McInerney discusses the preparedness of clinicians to understand and use personalized medicine in their practice.
What role will genetic counselors play in the future of genetic medicine?
What scientific background do genetic counselors have?
Dr. Katrina Armstrong outlines the ways in which current healthcare disparities may be alleviated by genomic information.
What level of uncertainty would make it worth using genetic risk assessment as a standard in healthcare?